RARγ Reporter Cellular Assay Pack
The RARγ Reporter Cellular Assay Pack provides all the key reagents required to monitor the activity of retinoic acid receptor gamma (RARγ). The pack contains the RARγ Reporter (Luc)-HEK293 Cell Line, a luciferase reporter cell line that contains a firefly luciferase gene under the control of retinoic acid response elements stably integrated into HEK293 cells along with full length human RARγ (GenBank Accession No. P13631-1). This cell line is functionally validated for the response to the stimulation of all-trans retinoic acid, and the expression of RARγ is confirmed by Western blotting.
Additionally, the pack includes cell culture medium (Thaw Medium 6) that has been optimized for use with HEK293 cells. Thaw Medium 6 includes 10% fetal bovine serum and 1% Pen/Strep. Finally, the pack provides the ONE-Step™ Luciferase Detection System. This reagent provides highly sensitive, stable detection of firefly (Photinus pyralis) luciferase activity. The ONE-Step luciferase reagent can be used directly in cells in growth medium, and can be detected with any luminometer; automated injectors are not required.
This product has been cited 2 times.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
• All-Trans Retinoic Acid (ATRA) (Sigma-Aldrich, #R2625): stock solution in DMSO
• 96-well tissue culture treated white clear-bottom assay plate (Corning, #3610)
• Luminometer
Category Number |
Component | Amount | Storage | |
60604 | RARγ Reporter (Luc) - HEK293 Cell Line | 2 vials* | -80°C | Avoid freeze/ thaw cycles! |
60690-1 |
ONE-Step Luciferase Buffer (Component A) | 10 ml | -20°C | |
ONE-Step Luciferase Reagent Substrate, 100x (Component B) | 100 µl | -20°C | ||
60183 | Thaw Medium 6 | 100 ml | +4°C |
*Each vial contains ~2 X 106 cells in 1 ml of 10% DMSO.
1. Petkovich, M, et al. Nature (1987) 330(6147): 444-450.
2. Allenby, G, et al. Proc. Natl. Acad. Sci. USA (1993) 90(1): 30-34.
Application Reference(s):
1. Selective Agonists of Nuclear Retinoic Acid Receptor Gamma Inhibit Growth of HCS-2/8 Chondrosarcoma Cells (2019)
2. Understanding the Action of RARγ Agonists on Human Osteochondroma Explants (2020)